Advertisement

Topics

J&J Deal Helps Zymeworks Continue Transformational Year

13:30 EST 13 Nov 2017 | SCRIP

Vancouver biotech says $50m up front from Janssen reflects clinical validation of its antibody technology platforms. Firm also moved first...

      

Related Stories

 

Original Article: J&J Deal Helps Zymeworks Continue Transformational Year

NEXT ARTICLE

More From BioPortfolio on "J&J Deal Helps Zymeworks Continue Transformational Year"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...